Cornea, cataract, refractive, and anterior segment surgery remain at the forefront of ophthalmic innovation, yet several challenges persist that demand critical reflection and collaborative solutions. As we navigate 2025, a few key issues warrant our attention.
Corneal transplantation is evolving with lamellar techniques like DMEK and DALK, but accessibility remains uneven, especially in low-resource settings.
2
Keratoconus management has improved with corneal cross-linking, but standardizing treatment protocols for pediatric patients is still a concern.
3
Ocular surface disease, including dry eye, is recognized as a public health issue, worsened by screen time and environmental factors.
4
Research into inflammatory pathways and the microbiome suggests potential for targeted therapies in ocular surface disease management.
5
Technological advancements and interdisciplinary collaboration are driving a transformative period in corneal and anterior segment surgery.
